How to invest in Techemy Capital’s non-custodial portfolios on Enzyme
Techemy Capital has launched two actively managed portfolios that allow investors to gain exposure to BTC/ETH price action and the DeFi sector. Trades are executed by Techemy Capital’s Josh Olszewicz. Investors can take advantage of crypto price moves without having to trade themselves - and because Techemy’s products are non-custodial - without releasing control of their assets.
Techemy Capital launches managed DeFi portfolio
The Managed DeFi Portfolio from Techemy Capital and Enzyme Finance will give wholesale and accredited investors access to the Ethereum DeFi Ecosystem at competitive rates.
Techemy Capital launches DeFi ETP on Balancer
Techemy Capital has launched decentralized Exchange-Traded Portfolios (ETPs) on Balancer, starting with a DeFi ETP. We’re joined by Techemy Capital CEO Fran Strajnar and Balancer CEO Fernando Martinelli who discuss why these ETPs are a potential game-changer, how to invest, and what this means for DeFi.
On-chain asset management with Enzyme Finance & Techemy Capital
Enzyme Finance is an Ethereum-based protocol for decentralized on-chain asset management. Enzyme empowers anyone to set up, manage and invest in customized on-chain investment vehicles. Techemy Capital has launched the non-custodial Holistic ETH-BTC Portfolio on Enzyme. This actively traded portfolio provides exposure to Bitcoin and Ethereum price action using Long/Short trading strategies designed and executed by Josh Olszewicz.
New report evaluates stablecoin contenders and the sector’s likely evolution
A comprehensive new report from Techemy Capital lifts the lid on participants in the current stablecoin ecosystem, identifying winning and losing business models, exploring underwriting options far beyond ‘cash in the bank’ and predicts the likely stablecoin market evolution through to 2022
